Repurposing of CAST Systems as Next-Generation Tools for Genome Engineering of Mammalian Cells

INTETOOLS aims to enhance genome engineering by repurposing CRISPR Associated Transposon systems for precise insertion of large DNA cargos in eukaryotic genomes, overcoming current limitations.

Subsidie
€ 2.475.491
2023

Projectdetails

Introduction

Genome editing using RNA-guided CRISPR-Cas nucleases (Clustered Regularly Interspaced Short Palindromic Repeats that associate with CRISPR associated proteins) has radically altered life sciences, enabling genome manipulation in living organisms. However, their use is limited by dependence on DNA Damage Response (DDR), which restricts genome editing to dividing cells.

Limitations of Current Techniques

Further, these nucleases cannot handle DNA cargos large enough to harbor regulatory DNA circuitry, thus precluding genome engineering. In INTETOOLS, I will overcome these limitations by dissecting and repurposing CRISPR Associated Transposon (CAST) systems into genome engineering tools.

Overview of CAST Systems

CASTs are naturally occurring prokaryotic protein–RNA machineries consisting of an inactive CRISPR effector complex, which associate with Tn7 family transposons to insert large DNA cargos. Knowledge of their molecular mechanisms is scarce, which prevents their practical application in genome engineering.

Objectives

Objective 1

In Objective 1, I will investigate the architecture of different CASTs to obtain fundamental knowledge of their RNA-guided integration.

Objective 2

I will then use this knowledge in Objective 2 to dissect their mechanism underpinnings whereby CRISPR-Cas complexes associate with transposition complexes to insert with nucleotide accuracy DNA cargos.

Objective 3

This will inform Objective 3, where I will design new CAST tools that will allow RNA-guided transposition in eukaryotic genomes. These revamped CASTs will be capable of inserting large DNAs with high precision, harboring regulatory regions into eukaryotic genomes, enabling genome engineering in eukaryotes.

Testing and Applications

I will test the redesigned CASTs in mammalian cell lines and at the organismal level by rescuing the eyeless mutant phenotype in Drosophila melanogaster.

Conclusion

INTETOOLS will catalyze a conceptual leap propelling the field into a new era of genome engineering, with major biomedical and biotechnological applications, especially in synthetic biology.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.475.491
Totale projectbegroting€ 2.475.491

Tijdlijn

Startdatum1-11-2023
Einddatum31-10-2028
Subsidiejaar2023

Partners & Locaties

Projectpartners

  • KOBENHAVNS UNIVERSITETpenvoerder

Land(en)

Denmark

Vergelijkbare projecten binnen European Research Council

ERC STG

MANUNKIND: Determinants and Dynamics of Collaborative Exploitation

This project aims to develop a game theoretic framework to analyze the psychological and strategic dynamics of collaborative exploitation, informing policies to combat modern slavery.

€ 1.497.749
ERC STG

Elucidating the phenotypic convergence of proliferation reduction under growth-induced pressure

The UnderPressure project aims to investigate how mechanical constraints from 3D crowding affect cell proliferation and signaling in various organisms, with potential applications in reducing cancer chemoresistance.

€ 1.498.280
ERC STG

Uncovering the mechanisms of action of an antiviral bacterium

This project aims to uncover the mechanisms behind Wolbachia's antiviral protection in insects and develop tools for studying symbiont gene function.

€ 1.500.000
ERC STG

The Ethics of Loneliness and Sociability

This project aims to develop a normative theory of loneliness by analyzing ethical responsibilities of individuals and societies to prevent and alleviate loneliness, establishing a new philosophical sub-field.

€ 1.025.860

Vergelijkbare projecten uit andere regelingen

ERC COG

In Vivo CRISPR-Based Nanoplatform for Gene Editing: A New Disruptive Avenue for Non-Invasive Treatment of Genetic Brain Diseases

This project aims to develop a novel nanoplatform for the safe and efficient delivery of CRISPR gene editing technology to treat genetic brain diseases non-invasively.

€ 2.249.895
ERC COG

In situ genetic perturbation of gut bacteria with engineered phage vectors and CRISPR

This project aims to develop synthetic biology tools for precise genetic manipulation of gut bacteria using phage vectors and CRISPR-Cas systems to enhance microbiome-targeted therapies.

€ 1.999.780
ERC STG

Transcriptional Engineering of Hematopoietic Stem Cells using CRISPR

This project aims to enhance hematopoietic stem cell therapies by using repurposed CRISPR/Cas systems for precise transcriptional manipulation of key genetic pathways.

€ 1.499.923
ERC STG

Profile nucleases and Repurpose Off-Targets to Expand Gene Editing

The PROTÉGÉ project aims to enhance gene editing safety and diversity by profiling programmable nucleases and exploring off-target effects for improved precision in genetic therapies.

€ 1.141.779